AGL Stock Recent News

agilon health has achieved its first quarter with over $1 billion in revenues, largely due to significant membership growth. AGL is taking strong steps to divert capital to buy back shares. The improvement in margins is necessary before the company could become a buy.

agilon health, inc. (NYSE:AGL ) Q1 2023 Results Conference Call May 9, 2023 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Lisa Gill - JPMorgan George Hill - Deutsche Bank Ryan Daniels - William Blair Justin Lake - Wolfe Research Carol Wong - Wells Fargo Securities Jailendra Singh - Truist Adam Ron - Bank of America Sean Dodge - RBC Capital Markets Ben Mayo - SVB Securities Jamie Perse - Goldman Sachs Gary Taylor - Cowen David Larsen - BTIG Brian Tanquilut - Jefferies Operator Thank you all for joining.

Agilon Health (AGL) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the following upcoming investor conferences. The BofA Securities 2023 Health Care Conference, including a fireside chat presentation on Thursday, May 11 at 11:40 AM Eastern Time. The RBC 2023 Global Healthcare Conference, including a fireside chat presentation on Tuesday, May 16 at 2:05 PM Eastern Time. A si.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2023 after the market closes on Tuesday, May 9, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S.

agilon health hosted its 2023 investor day, with positive updates on new health system partnerships and favorable updates to 2026 targets. Post the investor day, I have further conviction on AGL's value proposition.

agilon health recently reported its Q4 2022 financial results. The firm provides value-based healthcare solutions to seniors in the United States.

agilon health, Inc. (NYSE:AGL ) Q4 2022 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants Sandy Draper - Guggenheim Whit Mayo - SVB Securities Brian Tanquilut - Jefferies David Larsen - BTIG George Hill - Deutsche Bank Jamie Perse - Goldman Sachs Justin Lake - Wolfe Research Kevin Fischbeck - Bank of America Lisa Gill - JP Morgan Ryan Daniels - William Blair Sean Dodge - RBC Stephen Baxter - Wells Fargo Operator Hello, everybody, and welcome to the agilon health Fourth Quarter 2022 earnings call. My name is Sam, and I'll be coordinating your call today.

Agilon (AGL) delivered earnings and revenue surprises of -75% and 3.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AUSTIN, Texas--( BUSINESS WIRE )--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the fourth quarter and full year 2022 after the market closes on Wednesday, March 1, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.